This inventor holds 25 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Tumor Detection Methods. Top assignees: The Penn State Research Foundation, Oncomedx, Inc.. Active years: 2000-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hummelstown, PA (US) (2000 - 2003)
- Elliott City, MD (US) (2003 - 2011)
- Elliot City, MD (US) (2011)
- Ellicott City, MD (US) (2003 - 2013)
Company Filing History:
Years Active: 2000-2013
Areas of Expertise:
Title: Christopher D. Gocke: Innovator in Tumor-Associated Nucleic Acid Detection
Introduction
Christopher D. Gocke is an accomplished inventor based in Ellicott City, MD, recognized for his significant contributions to the field of cancer diagnostics. With a portfolio of 25 patents, Gocke has pioneered methods to detect tumor-associated DNA in plasma or serum, providing vital tools for diagnosing and monitoring various neoplastic conditions.
Latest Patents
Gocke's latest innovations include a groundbreaking method for detecting tumor-associated DNA in plasma or serum, specifically aimed at identifying extracellular nucleic acids that correlate with malignancies. This invention comprises the detection of mutant oncogenes and other tumor-related DNA, utilizing advanced techniques like rapid DNA extraction coupled with nucleic acid amplification. This pioneering method enables the early identification of cancers, including colorectal, pancreatic, lung, breast, bladder, and ovarian malignancies, and aids in monitoring the clinical status of patients with neoplastic disorders.
Career Highlights
Over the years, Christopher D. Gocke has worked with prominent organizations, including the Penn State Research Foundation and Oncomedx, Inc. His research and inventions have proven instrumental in advancing cancer diagnostics, ensuring better patient outcomes through early and accurate detection methods.
Collaborations
Throughout his career, Gocke has collaborated with notable colleagues such as Michael S. Kopreski and Floyd A. Benko. These partnerships have facilitated the development of innovative technologies geared towards improving cancer detection and treatment monitoring.
Conclusion
Christopher D. Gocke's work exemplifies the essential role of innovation in enhancing cancer diagnostics. Through his extensive patent portfolio and collaborative efforts, he continues to contribute significantly to the field, paving the way for improved methodologies in detecting and managing neoplastic diseases. His inventions underscore the importance of early detection in the fight against cancer, showcasing the impact of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile